Top Buy
Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Sangamo Therapeutics Inc. | 12 | 12 | 1 | 1 | €0.60 | €3.63 | 503.860% |
PTC Therapeutics Inc. | 15 | 7 | 3 | 2 | €35.20 | €42.12 | 19.646% |
Ocular Therapeutix Inc. | 8 | 5 | 1 | 0 | €5.42 | €12.21 | 125.486% |
Pfizer Inc. | 27 | 4 | 1 | 0 | €26.70 | €40.66 | 52.283% |
TG Therapeutics Inc. | 22 | 4 | 2 | 0 | €16.65 | €28.06 | 68.596% |
Immunic Inc. | 6 | 3 | 0 | 1 | €1.18 | €5.48 | 364.559% |
Universal Health Services B | 10 | 3 | 1 | 0 | €166.00 | €161.53 | -2.693% |
Community Health Systems Inc. | 4 | 3 | 1 | 0 | €3.38 | €5.36 | 58.710% |
Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.71 | €15.58 | -0.833% |
Radnet Inc. | 9 | 3 | 2 | 0 | €53.00 | €54.58 | 2.982% |
Agilent Technologies Inc. | 17 | 3 | 0 | 0 | €139.86 | €134.50 | -3.831% |
Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €4.54 | €4.62 | 1.674% |
Novavax Inc. | 5 | 3 | 3 | 2 | €14.03 | €9.80 | -30.168% |
Iovance Biotherapeutics Inc. | 20 | 3 | 1 | 0 | €9.30 | €22.78 | 144.896% |
Akebia Therapeutics Inc. | 8 | 2 | 0 | 0 | €1.02 | €3.64 | 256.944% |
Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €23.39 | €52.03 | 122.424% |
Codexis Inc. | 5 | 2 | 1 | 0 | €3.23 | €8.36 | 158.675% |
Vertex Pharmaceuticals Inc. | 46 | 2 | 6 | 0 | €413.35 | €416.05 | 0.653% |
Myriad Genetics | 6 | 2 | 1 | 0 | €22.40 | €24.18 | 7.950% |
Align Technology | 15 | 2 | 3 | 0 | €235.90 | €345.95 | 46.651% |
Phibro Animal Health Corp. A | 4 | 2 | 0 | 1 | €16.70 | €12.06 | -27.760% |
Incyte Corp. | 12 | 2 | 3 | 0 | €53.56 | €78.42 | 46.420% |
Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €14.10 | €21.86 | 55.048% |
Novocure Ltd | 1 | 1 | 0 | 0 | €21.03 | - | - |
Xencor Inc. | 10 | 1 | 1 | 0 | €22.00 | €32.58 | 48.086% |